Published in
Elsevier, The Lancet Oncology, 13(14), p. 1278-1286
DOI: 10.1016/s1470-2045(13)70490-x
Links
Tools
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
Journal article published in 2013 by
Yasuhide Yamada,
Daisuke Takahari 
,
Hiroshi Matsumoto,
Hideo Baba,
Masato Nakamura,
Kazuhiro Yoshida,
Motoki Yoshida,
Shigeyoshi Iwamoto,
Ken Shimada,
Yoshito Komatsu,
Yasutsuna Sasaki,
Taroh Satoh,
Keiichi Takahashi,
Hideyuki Mishima,
Kei Muro
and other authors.
,
Hiroshi Matsumoto,
Hideo Baba,
Masato Nakamura,
Kazuhiro Yoshida,
Motoki Yoshida,
Shigeyoshi Iwamoto,
Ken Shimada,
Yoshito Komatsu,
Yasutsuna Sasaki,
Taroh Satoh,
Keiichi Takahashi,
Hideyuki Mishima,
Kei Muro
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 